Results of a reevaluation of cardiovascular outcomes in the RECORD trial-Reference-Cited by-同舟云学术

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

Published:2013-08 Issue:2 Volume:166 Page:240-249.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Mahaffey Kenneth W.,Hafley Gail,Dickerson Sheila,Burns Shana,Tourt-Uhlig Sandra,White Jennifer,Newby L. Kristin,Komajda Michel,McMurray John,Bigelow Robert,Home Philip D.,Lopes Renato D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007

2. Rosiglitazone evaluated for cardiovascular outcomes—an interim analysis;Home;N Engl J Med,2007

3. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality;Nissen;Arch Intern Med,2010

4. Clinical Data Interchange Standards Consortium Web site. http://www.cdisc.org/.

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets;Biomolecules;2024-08-13

2. Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes;Journal of the Endocrine Society;2024-05-23

3. The evolution of type 2 diabetes management: glycemic control and beyond with SGLT-2 inhibitors and GLP-1 receptor agonists;Journal of Osteopathic Medicine;2023-11-03

4. Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-09-20

5. Insulin and Blood Pressure Relationships;Blood Pressure Disorders in Diabetes Mellitus;2023